Aclarion, Inc. (ACON) vs Scienture Holdings, Inc. (SCNX)
A side-by-side comparison of Aclarion, Inc. and Scienture Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACON
Aclarion, Inc.
$2.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCNX
Scienture Holdings, Inc.
$3.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ACON vs SCNX
growth of $100 · dividends reinvested · last 2yACON -99.0% (-89.8%/yr)SCNX -98.0% (-85.9%/yr)SCNX compounded faster over this window
ACON SCNX
ACON vs SCNX: by the numbers
- •ACON is the larger company ($7M vs $6M market cap).
- •Both run net losses; SCNX's is the smaller (-4620.92% vs -10978.48% net margin).
- •ACON grew revenue faster over the past five years (3.75% vs -42.69% CAGR).
Metrics side by side
Valuation
| Metric | ACON | SCNX |
|---|---|---|
| P/S ratio | 78.80 | 7.44 |
| P/B ratio | 0.39 | 0.10 |
Profitability
| Metric | ACON | SCNX |
|---|---|---|
| Gross margin | -291.27% | 76.80% |
| Operating margin | -9312.55% | -3763.78% |
| Net margin | -10978.48% | -4620.92% |
| ROE | -54.09% | -59.21% |
| ROIC | -57.11% | -15.99% |
Growth (annualized)
| Metric | ACON | SCNX |
|---|---|---|
| Revenue CAGR (5Y) | 3.75% | -42.69% |
Frequently asked
- Which has grown faster, ACON or SCNX?
- Over the past five years, ACON grew revenue faster — ACON at a 3.75% CAGR versus SCNX at -42.69%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.